Craig Coleman
Professor/Pharmacy Practice

Are you Craig Coleman?

How to update your information.
Scholarly Contributions

620 Scholarly Contributions

419
Journal Articles
137
Poster/Presentations
41
Other Scholarly Works
12
Digital and Electronic Media, Social Media, Blog, Podcast, Magazine/Trade Publications
6
Conference Proceedings
5
Book Chapters
PERSISTENCE OF REDUCED DOSE DOACS AND WARFARIN: A MULTINATIONAL COHORT STUDY OF INDIVIDUALS WITH INCIDENT AF
2023
Craig Coleman
Research Type: Poster/Presentation

2 Lower In-Hospital Mortality and Rebleeding Among Patients With Major Gastrointestinal Bleeding Treated With Andexanet Alfa vs 4-Factor Prothrombin Complex Concentrate. G Fermann, C Coleman, M Danese, E Lesén, M Christoph, R Chang,
2023
Craig Coleman
Research Type: Poster/Presentation

A Meta-Analysis of High-Dose Versus Low-Dose 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitor-Associated Intracerebral Hemorrhage
2023
Craig Coleman, William L Baker Jr.
Research Type: Poster/Presentation

A quality assessment of meta-analyses evaluating andexanet alfa and prothrombin complex concentrate (PCC) products.
2023
William L Baker Jr., Adrian V Hernandez Diaz, Kimberly Snow Caroti, Charles M White, Youssef Bessada, Paul Dobesh, Craig Coleman
Research Type: Poster/Presentation

Using 30-Day Modified Rankin Scale Score to Predict 90-Day Values in Individuals With Intracerebral Hemorrhage
2023
Craig Coleman, William L Baker Jr.
Research Type: Poster/Presentation

OC 31.2 Andexanet Alfa is Associated with Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients with Factor Xa Inhibitor–Related Major
2023
Craig Coleman
Research Type: Poster/Presentation

A meta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage
2023
Craig Coleman
Research Type: Poster/Presentation

Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study.
2024
Craig Coleman, B Schaefer, M Carrier, C Ay, C Wallenhorst, M Rivera, A Ekbom, G Brobert, A T Cohen, K Abdelgawwad, C Martinez, G Psaroudakis, C Becattini, A A Khorana
Research Type: Journal Article

Using 30-day modified rankin scale score to predict 90-day score in patients with intracranial hemorrhage: Derivation and validation of prediction model.
2024
William L Baker Jr., M J Christoph, B Koch, M Ouwens, G Frady, Craig Coleman, A Cohen, M Sharma, T E Moore
Research Type: Journal Article

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis.
2024
K Rhodes, Charles M White, Craig Coleman, H van Haalen, Youssef Bessada, K S Caroti, Adrian V Hernandez Diaz, P P Dobesh, William L Baker Jr.
Research Type: Journal Article

Agreement between 30-day and 90-day modified Rankin Scale score and utility-weighted modified Rankin Scale score in acute intracerebral hemorrhage: An analysis of ATACH-2 trial data.
2024
M J Christoph, A T Cohen, B Koch, William L Baker Jr., Craig Coleman, M Concha, B Lovelace
Research Type: Journal Article

Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
2024
G Brobert, C Becattini, K Vogtländer, M Linder, Craig Coleman, M Carrier, A A Khorana, A Ekbom, D H Giunta, Y Balabanova, A T Cohen, M Rivera, K Abdelgawwad, B Schaefer, G Psaroudakis
Research Type: Journal Article

Cost-Effectiveness of Olorofim in Invasive Aspergillosis Patients Lacking Suitable Alternative Treatment Options from a US Payer Perspective. ISPOR 2024, May 2024.
2024
Craig Coleman
Research Type: Poster/Presentation

Abstract WP231: The Incidence of Intracranial Hemorrhage in Patients Anticoagulated With Factor Xa Inhibitors (FXai): A Multi-Country Observational Study (AXIOM ICH).
2024
Craig Coleman
Research Type: Poster/Presentation

Indexing performance measure codes to enhance perceived value of EPC reports
Stephanie Chang, Charles M White, Kimberly Jackman, Craig Coleman
Research Type: Conference Proceedings

Can preoperative statin use reduce atrial fibrillation incidence after cardiac surgery?
Kirkeith Lertsburapa, Jeffrey Kluger, Craig Coleman, Charles M White, Osman Faheem
Research Type: Conference Proceedings

An evaluation of the safety of aprotinin use: The retrospective evaluation of aprotinin in Cardio thoracic surgery (REACTS) study
Jonathan Hammond, Vera T Rigali, Jeffrey Kluger, William L Baker Jr., Craig Coleman, Charles M White
Research Type: Conference Proceedings

Efficacy and Safety of Antihyperglycemic Agents Added to Metformin and Sulfonylurea Therapy in Type 2 Diabetes
Craig Coleman, Elizabeth S Mearns, Steven Lemieux, Christine G Kohn, Whitney J Saulsberry, Ilona Salamucha, Amanda Sihabout, Charles M White
Research Type: Conference Proceedings

Predictors of long term survival among patients receiving implantable cardioverter-defibrillators
Ravi Yarlagadda, Christopher Clyne, Jeffrey Kluger, Danette Guertin, Nitesh Sood, William L Baker Jr., Craig Coleman, Charles M White, Sanjeev P Bhavnani
Research Type: Conference Proceedings

Does the use of amiodarone impact the ability of anterior fat pad retention to prevent post-operative atrial fibrillation?
Jeffrey Kluger, Krista M Dale, Charles M White, Craig Coleman
Research Type: Conference Proceedings